MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jocs.15000

Медицинская библиотека · Journal of cardiac surgery · 2020

Surgical revision after percutaneous mitral valve repair by edge-to-edge device in high-risk patients.

Alozie Anthony, Westphal Bernd, Caglayan Evren, Yuecel Seyrani, Schubert Roland, Aydin Ali, Kletzin Frank, Öner Alper, Dohmen Pascal M, Bushnaq Hasan

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients scheduled for surgery after unsuccessful MitraClip® intervention present increasingly with multiple comorbidities, and they are often referred to the heart team to suggest the most appropriate intervention. The publication of successful results of initial patient cohorts treated with the MitraClip device has resulted in recruitment of more seriously ill patients, who otherwise would have been denied catheter-based/surgical treatment. There has been increasingly reports on conventional surgery after failed mitral valve repair with the MitraClip device. However, data on such procedures remain scarce and mostly focused on individual case studies. The inevitable increase in use of MitraClip, however, will raise the number of patients in need of surgery post MitraClip, making it imperative for surgeons to understand challenges and outcome data related with surgery in this patient cohort. We present our long-term institutional experience with surgery after MitraClip intervention in highest risk patients.

METHODS

Eighteen patients underwent surgery of the mitral valve at our Institution between January 2015 and June 2020. These patients developed recurrent mitral regurgitation grade more than 2° at various intervals after MitraClip. Mitral valve repair was performed where possible and gross examination Valve/MitraClip were intra-operatively documented. Implanted MitraClip devices were analyzed histopathologically to evaluate the healing process and rule out inflammation. Regular patient follow-up was performed.

RESULTS

Mean patient age was 74 (±9 years) and MitraClip implantation was performed at various tertiary institutions. Sixteen out of eighteen (16/18) patients received mitral valve replacement, whereas the remaining two patients received mitral valve repair and extracorporal membrane oxygenation, respectively. Four patients died of sepsis and intractable multi organ failure in-hospital. The remaining patients were discharged alive out of hospital to different rehabilitation centers. Follow-up was complete in all patients.

CONCLUSIONS

Surgery is demanding when patients require surgery for persistent or recurrent mitral regurgitation after MitraClip therapy and can be successfully implemented as a possible therapy option for selective cases as an interdisciplinary approach despite calculated high perioperative mortality risk. These patients should not be denied surgery outright.

Для цитирования: Alozie Anthony, Westphal Bernd, Caglayan Evren, Yuecel Seyrani, Schubert Roland, Aydin Ali, Kletzin Frank, Öner Alper, Dohmen Pascal M, Bushnaq Hasan. Surgical revision after percutaneous mitral valve repair by edge-to-edge device in high-risk patients.. Journal of cardiac surgery. 2020. DOI: 10.1111/jocs.15000.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.